|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Depreciation and amortization | |||||
| Net accretion of discount on available-for-sale securities | |||||
| Non-cash lease expense | |||||
| Gain on lease termination | |||||
| Loss on disposal of property and equipment | |||||
| Change in fair value of warrant liability | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Proceeds from maturities of investments | |||||
| Purchases of investments | |||||
| Purchases of property and equipment | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of common stock and warrants | |||||
| Proceeds from issuance of common stock related to employee stock purchase plan | |||||
| Proceeds from exercise of pre-funded warrants | |||||
| Proceeds from exercise of common stock options | |||||
| Payment of offering costs | |||||
| Payment of debt and equity offering costs | |||||
| Repayment of term loan | |||||
| Tax withholding payments on restricted stock units | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental cash flow data: | |||||
| Cash paid for interest on term loan | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Deferred offering costs included in accrued expenses | |||||
| Deferred offering costs included in accrued expenses and other current liabilities | |||||
| Right-of-use asset recognized in exchange for lease liability | |||||
| Reconciliation of cash, cash equivalents, and restricted cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash, short-term (included in other current assets) | |||||
| Restricted cash, long-term (included in other assets) | |||||
Loading...